申请人:Ciba-Geigy Corporation
公开号:US04014920A1
公开(公告)日:1977-03-29
Amines of the formula ##SPC1## Wherein R.sub.1 is lower alkyl, lower alkoxy or amino, R.sub.2 is hydrogen or lower alkyl, R.sub.3 is hydrogen, lower alkyl, carboxyl or lower alkoxycarbonyl, R.sub.4 is hydrogen or lower alkyl, R.sub.5 is lower alkyl, aryl-lower alkyl or optionally functionally modified carboxy-lower alkyl and R.sub.6 denotes halogen, trifluoromethyl, lower alkyl, lower alkenyl, lower alkoxy, lower alkenyloxy, nitro, lower alkoxymethyl, carbamoyl, N-lower alkylcarbamoyl, nitrile, lower alkinyloxy or hydrogen, and their salts block cardiac and vascular .beta.-receptors the are useful in the treatment of arrhythenias and angina pectoris and as intermediates for, especially for pharmaceutically active substances.
化合物的胺式##SPC1##其中R.sub.1是低烷基,低烷氧基或氨基,R.sub.2是氢或低烷基,R.sub.3是氢,低烷基,羧基或低烷氧羰基,R.sub.4是氢或低烷基,R.sub.5是低烷基,芳基-低烷基或可选择性功能修饰的羧基-低烷基,R.sub.6表示卤素,三氟甲基,低烷基,低烯基,低烷氧基,低烯基氧基,硝基,低烷氧甲基,氨基甲酰,N-低烷基氨基甲酰,腈,低炔氧基或氢,并且它们的盐可以阻断心脏和血管的β-受体,对于治疗心律失常和心绞痛以及作为特别是药物活性物质的中间体是有用的。